The Bethesda Review of Oncology
By (author) Jame Abraham M.D., James L. Gulley MD, PhD, FACP
Publication date:
01 March 2018Length of book:
320 pagesPublisher
LWWDimensions:
276x213mm8x11"
ISBN-13: 9781496354884
Perfect for any clinician short on time who needs to practice for oncology board exams, The Bethesda Review of Clinical Oncology is from the same authors who brought you the trusted and bestselling Bethesda Handbook of Clinical Oncology . It’s packed with hundreds of disease-specific questions that are formatted just like an actual board review exam—so you can prep as effectively as possible and achieve test success.
Enrich Your eBook Reading Experience with Enhanced Video, Audio and Interactive Capabilities!
- Features 500 review questions to help fellows and residents prepare for the American Board of Internal Medicine board review and MOC exams in medical oncology.
- Simulates an actual board review exam experience, with multiple-choice, single-best answer questions—and answer rationales—involving a hypothetical patient scenario.
- Aligns closely with content presented in the authors’ Bethesda Handbook of Clinical Oncology, also published by Lippincott Williams & Wilkins.
- Photos, illustrations, and other images provide visual context to each clinical scenario.
- All questions also available in an interactive online question bank—for anytime, anywhere, on-the-go access.
Enrich Your eBook Reading Experience with Enhanced Video, Audio and Interactive Capabilities!
- Read directly on your preferred device(s ), such as computer, tablet, or smartphone
- Easily convert to audiobook , powering your content with natural language text-to-speech
- Adapt for unique reading needs , supporting learning disabilities, visual/auditory impairments, second-language or literacy challenges, and more
“This fifth edition includes two new chapters, one on clinical
genetics and one on diagnosis-driven individualization of cancer care, that
cover targeted therapy and personalized medicine, areas critical to today's
practice of oncology.
This handbook is not intended to serve as an extensive and in-depth reference
work, rather it is meant to be a comprehensive review of the management of
different cancers including treatment regimens in a reader-friendly format.
It is well suited for oncologists, medical students, residents,
hematology/oncology fellows, oncology nurses, and, more broadly, anyone
interested in gleaning concise information on the subject.
This comprehensive review of more than 800 pages comprises 46 chapters devoted
to various cancers, including both solid tumors and hematological malignancies.
Despite the breadth, the book is designed for ready access to clinically
relevant information. To limit the size of the book, the authors place lesser
emphasis on disease etiology, pathophysiology, and epidemiology and greater
emphasis on practical considerations. Consistently, the endeavor combines
concise and helpful information with plentiful illustrations, tables, and
references. Chapter 46, on anticancer agents, is particularly impressive in its
description of the mechanism of action, approved indications, dosing,
schedules, adverse reactions, and comments on a large number of cancer drugs.
Written and edited by recognized experts from the National Cancer Institute,
National Institutes of Health, and other leading research institutions, this
comprehensive review is an outstanding resource.”
Weighted Numerical Score: 100 - 5 Stars!
Doodys Publishers' Club, June 2018
genetics and one on diagnosis-driven individualization of cancer care, that
cover targeted therapy and personalized medicine, areas critical to today's
practice of oncology.
This handbook is not intended to serve as an extensive and in-depth reference
work, rather it is meant to be a comprehensive review of the management of
different cancers including treatment regimens in a reader-friendly format.
It is well suited for oncologists, medical students, residents,
hematology/oncology fellows, oncology nurses, and, more broadly, anyone
interested in gleaning concise information on the subject.
This comprehensive review of more than 800 pages comprises 46 chapters devoted
to various cancers, including both solid tumors and hematological malignancies.
Despite the breadth, the book is designed for ready access to clinically
relevant information. To limit the size of the book, the authors place lesser
emphasis on disease etiology, pathophysiology, and epidemiology and greater
emphasis on practical considerations. Consistently, the endeavor combines
concise and helpful information with plentiful illustrations, tables, and
references. Chapter 46, on anticancer agents, is particularly impressive in its
description of the mechanism of action, approved indications, dosing,
schedules, adverse reactions, and comments on a large number of cancer drugs.
Written and edited by recognized experts from the National Cancer Institute,
National Institutes of Health, and other leading research institutions, this
comprehensive review is an outstanding resource.”
Weighted Numerical Score: 100 - 5 Stars!
Doodys Publishers' Club, June 2018